Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

National Institute for Health and Care Excellence NICE logo

Boehringer cancer drug on course for NHS use in UK

NICE backs Giotrif in draft guidance

- PMLiVE

Xtandi filed as pre-chemo prostate cancer therapy

Astellas and Medivation look to extend uses of their prostate cancer drug

- PMLiVE

GSK to hire doctors as product champions

Will use in-house personnel instead of external speakers to present information

Half of online Europeans watch health videos

But pharma yet to make the most of the medium as a patient engagement tool, says Manhattan Research

- PMLiVE

Life joins the Indigenus communications network

Windsor-based agency will be network's new UK partner

- PMLiVE

Ireland and the impact of reference pricing

Industry remains tight-lipped on the country's pharmaceutical pricing changes

- PMLiVE

Dawn of the new world

What the new NHS means for pharma and healthcare comms

- PMLiVE

Amgen cholesterol antibody shines in rare disease trial

Evolocumab passes late-stage study

- PMLiVE

Marino Garcia joins Synergy Pharmaceuticals

He has experience in gastrointestinal market at Aptalis

TxCell plans listing as EU biotech wakes up to IPOs

Move follows UK allergy therapy developer Circassia's listing

- PMLiVE

How will the new landscape of hepatitis C treatments affect patients?

For this 22 April webinar we bring together a panel of experts in hepatitis C to discuss this important topic, including a healthcare funder, a pharma medical director and an...

Bristol-Myers Squibb (BMS) building

BMS strikes $350m deal to boost its immuno-oncology pipeline

Will collaborate with US biotech Five Prime Therapeutics

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links